Orbital lymphangiomas: a review of management strategies

Curr Opin Ophthalmol. 2012 Sep;23(5):433-8. doi: 10.1097/ICU.0b013e3283560a99.

Abstract

Purpose of review: Orbital lymphangiomas present a difficult management problem for the ophthalmologist. This review offers a strategy for managing the condition.

Recent findings: There have been recent publications discussing the use of intralesional fibrin glue to aid dissection and intralesional sclerosant to shrink the lesion. We discuss the evidence for these treatments and present a case in which these treatments were combined.

Summary: This review highlights the classification and presents management options for orbital lymphangioma. We encourage a holistic and individualized approach to the patients, recognizing the variety of clinical manifestations that the condition can cause. In the event of surgical excision, we present the evidence for the use of intralesional fibrin glue and intralesional sclerosant, and describe using both in the same case.

Publication types

  • Review

MeSH terms

  • Fibrin Tissue Adhesive
  • Humans
  • Injections, Intralesional
  • Lymphangioma / classification
  • Lymphangioma / diagnosis
  • Lymphangioma / therapy*
  • Orbital Neoplasms / classification
  • Orbital Neoplasms / diagnosis
  • Orbital Neoplasms / therapy*
  • Sclerosing Solutions / therapeutic use

Substances

  • Fibrin Tissue Adhesive
  • Sclerosing Solutions